Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones03-21

DJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. $(INCY)$ advanced 2.21% to $61.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.08% to 5,667.56 and the Dow Jones Industrial Average rising 0.08% to 41,985.35.

This was the stock's third consecutive day of gains.

Incyte Corp. closed 26.24% below its 52-week high of $83.95, which the company achieved on November 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 11.75% to $283.34, Bio-Techne Corp. $(TECH)$ rose 0.45% to $60.61, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.50% to $71.24.

Trading volume (4.3 M) eclipsed its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 21, 2025 17:18 ET (21:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2521925729?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-22 05:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2521925729","market":"fut","top_or_hot":-1,"title":"Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> advanced 2.21% to $61.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.08% to 5,667.56 and the Dow Jones Industrial Average  rising 0.08% to 41,985.35. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Incyte Corp. closed 26.24% below its 52-week high of $83.95, which the company achieved on November 8th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 11.75% to $283.34, Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> rose 0.45% to $60.61, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> fell 0.50% to $71.24. \n</p>\n<p>\n     Trading volume (4.3 M) eclipsed its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 21, 2025 17:18 ET (21:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIncyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-22 05:18</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> advanced 2.21% to $61.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.08% to 5,667.56 and the Dow Jones Industrial Average  rising 0.08% to 41,985.35. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Incyte Corp. closed 26.24% below its 52-week high of $83.95, which the company achieved on November 8th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 11.75% to $283.34, Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> rose 0.45% to $60.61, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> fell 0.50% to $71.24. \n</p>\n<p>\n     Trading volume (4.3 M) eclipsed its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 21, 2025 17:18 ET (21:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2521925729","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2521925729","pubTimestamp":1742591880,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  advanced 2.21% to $61.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.08% to 5,667.56 and the Dow Jones Industrial Average  rising 0.08% to 41,985.35.This was the stock's third consecutive day of gains.Incyte Corp. closed 26.24% below its 52-week high of $83.95, which the company achieved on November 8th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc.  rose 11.75% to $283.34, Bio-Techne Corp.  rose 0.45% to $60.61, and BioMarin Pharmaceutical Inc.  fell 0.50% to $71.24.Trading volume  eclipsed its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"尽管每日上涨，但与竞争对手相比，Incyte Corp.股票周五表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INCY":1},"content_text":"DJ Incyte Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Incyte Corp. $(INCY)$ advanced 2.21% to $61.92 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.08% to 5,667.56 and the Dow Jones Industrial Average  rising 0.08% to 41,985.35. \n\n\n     This was the stock's third consecutive day of gains. \n\n\n     Incyte Corp. closed 26.24% below its 52-week high of $83.95, which the company achieved on November 8th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 11.75% to $283.34, Bio-Techne Corp. $(TECH)$ rose 0.45% to $60.61, and BioMarin Pharmaceutical Inc. $(BMRN)$ fell 0.50% to $71.24. \n\n\n     Trading volume (4.3 M) eclipsed its 50-day average volume of 1.8 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 17:18 ET (21:18 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2521925729"}